Clinical outcome study of crizotinib in IHC proven EML4-ALK fusion gene among Indian patients with adenocarcinoma lung

被引:0
|
作者
Batra, U. [1 ]
Sharma, M. [2 ]
Jain, A. [1 ]
Agarwal, M. [1 ]
Goyal, P. [2 ]
机构
[1] Rajiv Gandhi Canc Inst & Res Ctr, Med Oncol, New Delhi, India
[2] Rajiv Gandhi Canc Inst, Med Oncol, Delhi, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
469P
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [31] Differential Sensitivity to Crizotinib: Does EML4-ALK Fusion Variant Matter?
    Lin, Jessica J.
    Shaw, Alice T.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) : 3363 - +
  • [32] A Case of Small Cell Lung Carcinoma Harboring an EML4-ALK Fusion with Partial Response to Crizotinib
    Shen, Qian
    Kalyani, Farhin Shaheed
    Qu, Jingjing
    Chen, Zhen
    Zhang, Jing
    Zhou, Jianying
    CLINICAL LUNG CANCER, 2021, 22 (06) : E799 - E803
  • [33] Good Response to Gefitinib in Lung Adenocarcinoma Harboring Coexisting EML4-ALK Fusion Gene and EGFR Mutation
    Kuo, Yao-Wen
    Wu, Shang-Gin
    Ho, Chao-Chi
    Shih, Jin-Yuan
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : 2039 - 2040
  • [34] A Case of Lung Adenocarcinoma Resistant to Crizotinib Harboring a Novel EML4-ALK Variant, Exon 6 of EML4 Fused to Exon 18 of ALK
    Anai, Satoshi
    Takeshita, Masafumi
    Ando, Nobuhisa
    Ikematsu, Yuuki
    Mishima, Shohei
    Ishida, Koichi
    Inoue, Kouji
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : E126 - +
  • [35] PREVALENCE OF EML4-ALK FUSION GENE IN ADENOCARCINOMA LUNG PATIENTS BY USING IMMUNOHISTOCHEMISTRY: A PILOT STUDY FROM CANCER CENTRE IN NORTHERN INDIA
    Mehta, A.
    Talwar, V.
    RESPIRATORY MEDICINE, 2017, 132 : 270 - 271
  • [36] EML4-ALK AND OTHER FUSION KINASES IN LUNG CANCER
    Mano, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S438 - S438
  • [37] Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: A case report
    Ohba, Taro
    Sugio, Kenji
    Kometani, Takuro
    Yamaguchi, Masafumi
    Hamatake, Motoharu
    Nosaki, Kaname
    Takeoka, Hiroaki
    Kitajima, Hiromoto
    Hirai, Fumihiko
    Seto, Takashi
    Taguchi, Kenichi
    Nishiyama, Kenichi
    Shida, Yoshitaka
    Ichinose, Yukito
    LUNG CANCER, 2011, 73 (03) : 375 - 378
  • [38] Response to crizotinib in a lung adenocarcinoma patient harboring EML4-ALK translocation with adnexal metastasis A Case Report
    Wang, Wenxian
    Wu, Wei
    Zhang, Yiping
    MEDICINE, 2016, 95 (30)
  • [39] Atypical Lung Carcinoids with EML4-ALK Fusion and Responses to ALK Inhibitors
    Waliany, Sarah
    Hung, Yin P.
    Abu Rous, Fawzi
    Do, Andrew
    Peterson, Jennifer
    Meservey, Caitlin
    Digumarthy, Subba R.
    Gadgeel, Shirish M.
    Lin, Jessica J.
    Meadori, Catherine B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E32 - E33
  • [40] Synchronal pulmonary sarcomatoid carcinoma and lung adenocarcinoma EML4-ALK fusion: A case report
    Wang, Mingting
    Gong, Yifan
    Cheng, Yun
    Yang, Lei
    Wang, Wenhui
    Lei, Xiaolin
    ONCOLOGY LETTERS, 2022, 24 (04)